Search
for
Sort by
Research 121–150 of 656
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- INFLUENCE OF THE TYPE AND STYLE OF FEVER, SMOKING STATUS, DEGREE OF ANDROGENETIC ALOPECIA ON THE PHASES OF HAIR GROWTH IN MILITARY SERVICEMEN UNDER INPATIENT TREATMENT WITH A DIAGNOSIS OF PNEUMONIA
- Immediate Post-Operative Folliculitis: A Foreign Body Reaction, Not an Infection
- Feline trypanosomosis in a free-ranging domestic shorthair cat (Felis catus)
- A case of alopecia areata after rabies vaccination: unreported adverse effect?
- Physiological Importance of the Vitaminoid Thiocyanate and Its Influence on Hair Growth
- Editor’s picks January 2021
- Drug Information Analysis Service
- ALOPECIA AREATA
- Phytochemical, Toxicological and Pharmacological Studies of <i>Asiasari Radix</i> et Rhizoma: A Review
- Severe cutaneous adverse reactions to drugs
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Hormone replacement therapy and the skin
- Estrogens and the skin
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Nutrition and Hair
- Delivery and targeting of nanoparticles into hair follicles
- Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia
- Toxic Epidermal Necrolysis
- Safety of dermatologic medications in pregnancy and lactation
- Niosomes as a propitious carrier for topical drug delivery
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Management of congenital ichthyoses: European guidelines of care, part two